As of 2024-12-14, the Relative Valuation of Rocket Pharmaceuticals Inc (RCKT) is (51.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.57 USD, the upside of Rocket Pharmaceuticals Inc based on Relative Valuation is -508.8%.
The range of the Relative Valuation is (31.93) - (54.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 24.4x | 17.5x |
| Forward P/E multiples | 11.3x - 19.1x | 18.8x |
| Fair Price | (31.93) - (54.13) | (51.38) |
| Upside | -354.1% - -530.6% | -508.8% |
| Date | P/E |
| 2024-12-10 | -4.77 |
| 2024-12-09 | -4.89 |
| 2024-12-06 | -4.91 |
| 2024-12-05 | -4.70 |
| 2024-12-04 | -4.80 |
| 2024-12-03 | -4.77 |
| 2024-12-02 | -5.09 |
| 2024-11-29 | -5.08 |
| 2024-11-27 | -5.02 |
| 2024-11-26 | -4.98 |
| 2024-11-25 | -4.98 |
| 2024-11-22 | -4.98 |
| 2024-11-21 | -4.52 |
| 2024-11-20 | -4.61 |
| 2024-11-19 | -4.65 |
| 2024-11-18 | -4.83 |
| 2024-11-15 | -4.94 |
| 2024-11-14 | -5.23 |
| 2024-11-13 | -5.54 |
| 2024-11-12 | -5.66 |
| 2024-11-11 | -5.96 |
| 2024-11-08 | -6.16 |
| 2024-11-07 | -6.09 |
| 2024-11-06 | -6.21 |
| 2024-11-05 | -6.07 |
| 2024-11-04 | -5.94 |
| 2024-11-01 | -6.00 |
| 2024-10-31 | -5.88 |
| 2024-10-30 | -5.99 |
| 2024-10-29 | -6.13 |
| 2024-10-28 | -6.18 |
| 2024-10-25 | -6.02 |
| 2024-10-24 | -6.08 |
| 2024-10-23 | -6.21 |
| 2024-10-22 | -6.25 |
| 2024-10-21 | -6.22 |
| 2024-10-18 | -6.65 |
| 2024-10-17 | -6.51 |
| 2024-10-16 | -6.38 |
| 2024-10-15 | -5.89 |
| 2024-10-14 | -5.97 |
| 2024-10-11 | -6.04 |
| 2024-10-10 | -5.85 |
| 2024-10-09 | -5.87 |
| 2024-10-08 | -6.09 |
| 2024-10-07 | -5.92 |
| 2024-10-04 | -5.80 |
| 2024-10-03 | -5.67 |
| 2024-10-02 | -5.99 |
| 2024-10-01 | -6.05 |